Shares of Medical Instruments & Supplies company Baxter International climbed 2.2% this afternoon. Here are some quick facts to get you started if you are interested in the stock:
-
Baxter International has logged a -47.4% 52 week change, compared to -8.5% for the S&P 500
-
BAX has an average analyst rating of buy and is -13.9% away from its mean target price of $48.09 per share
-
Its trailing earnings per share (EPS) is $-4.83, which brings its trailing Price to Earnings (P/E) ratio to -8.6. The Health Care sector's average P/E ratio is 24.45
-
The company's forward earnings per share (EPS) is $3.29 and its forward P/E ratio is 12.6
-
The company has a Price to Book (P/B) ratio of 3.6 in contrast to the Health Care sector's average P/B ratio is 4.16
-
The current ratio is currently 1.7, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
BAX has reported YOY quarterly earnings growth of -23.4% and gross profit margins of 0.4%
-
The company's free cash flow for the last fiscal year was $532,000,000.00 and the average free cash flow growth rate is -0.2%
-
Baxter International's revenues have an average growth rate of 0.1% with operating expenses growing at 0.0%. The company's current operating margins stand at 6.2%
